Literature DB >> 10218537

Failure of the clonidine growth hormone stimulation test to differentiate multiple system atrophy from early or advanced idiopathic Parkinson's disease.

C E Clarke, P S Ray, J M Speller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10218537

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Multiple system atrophy: pathophysiology and management.

Authors:  G K Wenning; S Braune
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Biomarkers for cognitive impairment in Parkinson disease.

Authors:  Min Shi; Bertrand R Huber; Jing Zhang
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

3.  Prospective study of relevance of 123I-MIBG myocardial scintigraphy and clonidine GH test to distinguish Parkinson's disease and multiple system atrophy.

Authors:  C Alves Do Rego; I J Namer; C Marcel; F Lefebvre; O Lagha-Boukbiza; M Renaud; C Tranchant; M Anheim
Journal:  J Neurol       Date:  2018-06-28       Impact factor: 4.849

Review 4.  Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease.

Authors:  Maria Teresa Pellecchia; Rosario Pivonello; Annamaria Colao; Paolo Barone
Journal:  Clin Med Res       Date:  2006-12

5.  The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathic Parkinson's disease.

Authors:  Kezhong Zhang; Yanyin Zeng; Chunjie Song; Yu Fu; Qi Wan
Journal:  J Neurol       Date:  2010-04-20       Impact factor: 4.849

6.  Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease.

Authors:  C E Clarke; P Davies
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

Review 7.  Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review.

Authors:  Sarah Jesse; Petra Steinacker; Stefan Lehnert; Frank Gillardon; Bastian Hengerer; Markus Otto
Journal:  CNS Neurosci Ther       Date:  2009-03-09       Impact factor: 5.243
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.